Reed, Steven

Publications

Sort by

Co-Author Network

selected publications

Diagnostic potential of GLP recombinant antigens in whole blood assays for Leishmania infantum infection. Parasites & vectors. 2025 Academic Article GET IT
Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques. iScience. 2025 Academic Article GET IT
Times cited: 1
The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa. Vaccines. 2025 Academic Article GET IT
Synthetic RIG-I-Agonist RNA Induces Death of Hepatocellular Carcinoma Cells. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2025 Academic Article GET IT
Times cited: 2
Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of Leishmania major in cutaneous leishmaniasis patients. Frontiers in microbiology. 2025 Academic Article GET IT
Times cited: 2
Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability. Journal of controlled release : official journal of the Controlled Release Society. 2024 Academic Article GET IT
Times cited: 4
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans. Frontiers in immunology. 2024 Academic Article GET IT
Make it a combo. Science translational medicine. 2024 Review GET IT
Times cited: 1
ELISA with recombinant antigen Lb6H validated for the diagnosis of American tegumentary leishmaniasis. PloS one. 2024 Academic Article GET IT
Times cited: 5
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. NPJ vaccines. 2024 Academic Article GET IT
Times cited: 7
CD4⁺ T Cell Responses to Toxoplasma gondii Are a Double-Edged Sword. Vaccines. 2023 Academic Article GET IT
Times cited: 1
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation. Molecular therapy : the journal of the American Society of Gene Therapy. 2023 Academic Article GET IT
Times cited: 39
sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients. Frontiers in medicine. 2023 Academic Article GET IT
Times cited: 2
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. 2023 GET IT
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. 2023 GET IT
Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Infectious diseases and therapy. 2023 Academic Article GET IT
Times cited: 21
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis. Vaccines. 2023 Academic Article GET IT
Times cited: 49
Association between asthma, rhinitis and atopic dermatitis with leprosy: A case-control study. Indian journal of dermatology, venereology and leprology. 2023 Academic Article GET IT
Times cited: 3
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen. Tuberculosis (Edinburgh, Scotland). 2022 Academic Article GET IT
Times cited: 17
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease. Virulence. 2022 Academic Article GET IT
Times cited: 9
Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs. Pathogens (Basel, Switzerland). 2022 Review GET IT
Times cited: 7
Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women. Vaccines. 2022 Academic Article GET IT
Times cited: 17
Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations. Frontiers in microbiology. 2022 Academic Article GET IT
Times cited: 14
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21. NPJ vaccines. 2022 Academic Article GET IT
Times cited: 15
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines. 2021 Review GET IT
Times cited: 36
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant. Microorganisms. 2021 Academic Article GET IT
Times cited: 15
Novel polyprotein antigens designed for improved serodiagnosis of bovine tuberculosis. Veterinary immunology and immunopathology. 2021 Academic Article GET IT
Times cited: 7
Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection. Memorias do Instituto Oswaldo Cruz. 2021 Academic Article GET IT
Times cited: 10
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model. PloS one. 2021 Academic Article GET IT
Times cited: 32
Evolution of antigen-specific immune responses in cutaneous leishmaniasis patients. Parasite immunology. 2021 Academic Article GET IT
Times cited: 2
Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases. Applied microbiology and biotechnology. 2021 Review GET IT
Times cited: 8
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. The Lancet. Respiratory medicine. 2020 Academic Article GET IT
Times cited: 85
Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice. Scientific reports. 2020 Academic Article GET IT
Times cited: 24
New horizons in adjuvants for vaccine development. Current opinion in immunology. 2020 Review GET IT
Times cited: 47
Isolation and characterisation of Leishmania donovani protein antigens from urine of visceral leishmaniasis patients. PloS one. 2020 Academic Article GET IT
Times cited: 7
Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics. Nature biomedical engineering. 2020 Academic Article GET IT
Times cited: 46
The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patients. AMB Express. 2020 Academic Article GET IT
Times cited: 10
An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Science translational medicine. 2020 Academic Article GET IT
Times cited: 212
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates. Science immunology. 2020 Academic Article GET IT
Times cited: 115
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection. Molecular therapy. Methods & clinical development. 2020 Academic Article GET IT
Times cited: 86
Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates. 2020 GET IT
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge. Cell reports. 2020 Academic Article GET IT
Times cited: 47
Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection. Applied microbiology and biotechnology. 2020 Academic Article GET IT
Times cited: 6
Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization. Cell reports. 2020 Academic Article GET IT
Times cited: 20
Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cells. Nanoscale. 2020 Academic Article GET IT
Times cited: 21
Adjuvants. Current topics in microbiology and immunology. 2020 Review GET IT
Times cited: 9
A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults. Vaccine. 2019 Academic Article GET IT
Times cited: 27
Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs. Vaccine: X. 2019 Academic Article GET IT
Times cited: 22
Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model. Scientific reports. 2019 Academic Article GET IT
Times cited: 43
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Academic Article GET IT
Times cited: 122
Development of plasmonic ELISA for the detection of anti-Leishmania sp. IgG antibodies. Journal of immunological methods. 2019 Academic Article GET IT
Times cited: 12
A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy. Journal of pharmaceutical sciences. 2019 Academic Article GET IT
Times cited: 24
Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum. PLoS neglected tropical diseases. 2019 Academic Article GET IT
Times cited: 16
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology. NPJ vaccines. 2019 Academic Article GET IT
Times cited: 87
Mycobacterium leprae Recombinant Antigen Induces High Expression of Multifunction T Lymphocytes and Is Promising as a Specific Vaccine for Leprosy. Frontiers in immunology. 2018 Academic Article GET IT
Times cited: 10
Correlates of GLA family adjuvants' activities. Seminars in immunology. 2018 Review GET IT
Times cited: 48
Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist Activity. Journal of immunology (Baltimore, Md. : 1950). 2018 Academic Article GET IT
Times cited: 18
Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani. Frontiers in immunology. 2018 Academic Article GET IT
Times cited: 54
Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control. Future microbiology. 2018 Editorial Article GET IT
Times cited: 4
Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients. BMC infectious diseases. 2018 Academic Article GET IT
Times cited: 15
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen. NPJ vaccines. 2018 Academic Article GET IT
Times cited: 15
The adjuvant GLA-AF enhances human intradermal vaccine responses. Science advances. 2018 Academic Article GET IT
Times cited: 38
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial. NPJ vaccines. 2018 Academic Article GET IT
Times cited: 152
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika. Molecular therapy : the journal of the American Society of Gene Therapy. 2018 Academic Article GET IT
Times cited: 146
Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy. Annals of the New York Academy of Sciences. 2018 Academic Article GET IT
Times cited: 54
Control of Heterologous Simian Immunodeficiency Virus SIV_smE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques. Journal of virology. 2018 Academic Article GET IT
Times cited: 32
Erratum: Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection. 2018 GET IT
Times cited: 1
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial. The Lancet. Respiratory medicine. 2018 Academic Article GET IT
Times cited: 141
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection. NPJ vaccines. 2018 Academic Article GET IT
Times cited: 51
Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection. Frontiers in immunology. 2018 Academic Article GET IT
Times cited: 22
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models. Cell reports. 2017 Academic Article GET IT
Times cited: 76
Identification of Novel Antigens Recognized by Serum Antibodies in Bovine Tuberculosis. Clinical and vaccine immunology : CVI. 2017 Academic Article GET IT
Times cited: 19
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis. PLoS neglected tropical diseases. 2017 Academic Article GET IT
Times cited: 40
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations. Nature communications. 2017 Academic Article GET IT
Times cited: 64
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment. PloS one. 2017 Academic Article GET IT
Times cited: 76
Protein nanovaccine confers robust immunity against Toxoplasma. NPJ vaccines. 2017 Academic Article GET IT
Times cited: 53
Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120. Journal of virological methods. 2017 Academic Article GET IT
Times cited: 2
A defined subunit vaccine that protects against vector-borne visceral leishmaniasis. NPJ vaccines. 2017 Academic Article GET IT
Times cited: 31
Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines. Vaccine. 2017 Academic Article GET IT
Times cited: 23
Innovative tools and approaches to end the transmission of Mycobacterium leprae. The Lancet. Infectious diseases. 2017 Review GET IT
Times cited: 48
Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis. Clinical and vaccine immunology : CVI. 2017 Review GET IT
Times cited: 21
Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions. Scandinavian journal of immunology. 2017 Academic Article GET IT
Times cited: 31
CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination. Vaccine. 2017 Academic Article GET IT
Times cited: 32
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge. Nature communications. 2017 Academic Article GET IT
Times cited: 118
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines. Scientific reports. 2017 Academic Article GET IT
Times cited: 78
sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis. PLoS neglected tropical diseases. 2017 Academic Article GET IT
Times cited: 33
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide. Science translational medicine. 2017 Academic Article GET IT
Times cited: 77
The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy. Infectious diseases of poverty. 2017 Review GET IT
Times cited: 89
Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2017 Review GET IT
Times cited: 10
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines. Infection and immunity. 2017 Academic Article GET IT
Times cited: 54
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants. Scientific reports. 2016 Academic Article GET IT
Times cited: 50
Use of Recombinant Antigens for Sensitive Serodiagnosis of American Tegumentary Leishmaniasis Caused by Different Leishmania Species. Journal of clinical microbiology. 2016 Academic Article GET IT
Times cited: 27
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism. Journal of immunology (Baltimore, Md. : 1950). 2016 Academic Article GET IT
Times cited: 7
Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach. Journal of controlled release : official journal of the Controlled Release Society. 2016 Academic Article GET IT
Times cited: 54
A structure-function approach to optimizing TLR4 ligands for human vaccines. Clinical & translational immunology. 2016 Academic Article GET IT
Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. Journal of immunology (Baltimore, Md. : 1950). 2016 Academic Article GET IT
Times cited: 88
IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants. Journal of immunology (Baltimore, Md. : 1950). 2016 Academic Article GET IT
Times cited: 37
Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii. JCI insight. 2016 Academic Article GET IT
Times cited: 55
Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO. PLoS neglected tropical diseases. 2016 Academic Article GET IT
Times cited: 35
Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant. Vaccine. 2016 Academic Article GET IT
Times cited: 30
Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites. Clinical and vaccine immunology : CVI. 2016 Academic Article GET IT
Times cited: 12
The science of vaccine adjuvants: advances in TLR4 ligand adjuvants. Current opinion in immunology. 2016 Review GET IT
Times cited: 67
Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis. Parasites & vectors. 2016 Academic Article GET IT
Times cited: 39
An rK28-Based Immunoenzymatic Assay for the Diagnosis of Canine Visceral Leishmaniasis in Latin America. The American journal of tropical medicine and hygiene. 2016 Academic Article GET IT
Times cited: 14
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis. Vaccine. 2016 Academic Article GET IT
Times cited: 34
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PloS one. 2016 Academic Article GET IT
Times cited: 19
In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant. Cytokine. 2016 Academic Article GET IT
Times cited: 47
Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K. Vaccine. 2016 Academic Article GET IT
Times cited: 29
Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen. Vaccine. 2016 Academic Article GET IT
Times cited: 36
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. PloS one. 2016 Academic Article GET IT
Times cited: 30
Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined Antigens. Journal of clinical microbiology. 2016 Academic Article GET IT
Times cited: 22
The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14. PLoS neglected tropical diseases. 2016 Academic Article GET IT
Times cited: 86
The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction. PloS one. 2016 Academic Article GET IT
Times cited: 51
Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate. Clinical and vaccine immunology : CVI. 2015 Academic Article GET IT
Times cited: 56
Leishmania vaccine development: exploiting the host-vector-parasite interface. Expert review of vaccines. 2015 Review GET IT
Times cited: 50
Multi-epitope proteins for improved serological detection of Trypanosoma cruzi infection and Chagas Disease. Diagnostic microbiology and infectious disease. 2015 Academic Article GET IT
Times cited: 10
Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults. Vaccine. 2015 Academic Article GET IT
Times cited: 93
Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy. Vaccine. 2015 Academic Article GET IT
Times cited: 44
Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in Macrophages. PloS one. 2015 Academic Article GET IT
Times cited: 18
Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis. BMC infectious diseases. 2015 Academic Article GET IT
Times cited: 42
Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2015 Academic Article GET IT
Times cited: 33
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains. Infection and immunity. 2015 Academic Article GET IT
Times cited: 54
Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy. Diagnostic microbiology and infectious disease. 2015 Academic Article GET IT
Times cited: 19
A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates. Science translational medicine. 2015 Academic Article GET IT
Times cited: 112
The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age. Biogerontology. 2015 Academic Article GET IT
Times cited: 14
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes. Infection and immunity. 2015 Academic Article GET IT
Times cited: 39
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis. The Journal of infectious diseases. 2015 Academic Article GET IT
Times cited: 28
Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients. The American journal of tropical medicine and hygiene. 2014 Academic Article GET IT
Times cited: 38
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate. PloS one. 2014 Academic Article GET IT
Times cited: 43
Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis. Journal of immunology (Baltimore, Md. : 1950). 2014 Academic Article GET IT
Times cited: 38
The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivative. Clinical and vaccine immunology : CVI. 2014 Academic Article GET IT
Times cited: 19
Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis. Infection and immunity. 2014 Academic Article GET IT
Times cited: 28
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7. Journal of nanobiotechnology. 2014 Academic Article GET IT
Times cited: 74
DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques. PloS one. 2014 Academic Article GET IT
Times cited: 45
A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate. Diagnostic microbiology and infectious disease. 2014 Academic Article GET IT
Times cited: 59
GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza. PloS one. 2014 Academic Article GET IT
Times cited: 38
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen. PloS one. 2014 Academic Article GET IT
Times cited: 31
Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons. The Journal of infectious diseases. 2014 Academic Article GET IT
Times cited: 46
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons. Vaccine. 2014 Academic Article GET IT
Times cited: 53
A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93. PloS one. 2014 Academic Article GET IT
Times cited: 70
Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization. Journal of controlled release : official journal of the Controlled Release Society. 2013 Academic Article GET IT
Times cited: 46
Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy. Journal of clinical microbiology. 2013 Academic Article GET IT
Times cited: 71
Key roles of adjuvants in modern vaccines. Nature medicine. 2013 Review GET IT
Times cited: 1169
TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses. Vaccine. 2013 Academic Article GET IT
Times cited: 31
Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis. Tuberculosis (Edinburgh, Scotland). 2013 Academic Article GET IT
Times cited: 10
Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle. Vaccine. 2013 Academic Article GET IT
Times cited: 15
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis. Journal of controlled release : official journal of the Controlled Release Society. 2013 Academic Article GET IT
Times cited: 97
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells. Journal of immunology (Baltimore, Md. : 1950). 2013 Academic Article GET IT
Times cited: 30
Adjuvants containing natural and synthetic Toll-like receptor 4 ligands. Expert review of vaccines. 2013 Review GET IT
Times cited: 29
Vaccine adjuvants. Expert review of vaccines. 2013 Article GET IT
Times cited: 5
HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques. Vaccine. 2013 Academic Article GET IT
Times cited: 67
Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver. Infection and immunity. 2013 Academic Article GET IT
Times cited: 43
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment. The Journal of infectious diseases. 2012 Academic Article GET IT
Times cited: 95
Adjuvants for human vaccines. Current opinion in immunology. 2012 Review GET IT
Times cited: 196
The importance of adjuvant formulation in the development of a tuberculosis vaccine. Journal of immunology (Baltimore, Md. : 1950). 2012 Academic Article GET IT
Times cited: 100
Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate. Vaccine. 2011 Academic Article GET IT
Times cited: 39
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. PloS one. 2011 Academic Article GET IT
Times cited: 285
A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis. Science translational medicine. 2010 Academic Article GET IT
Times cited: 284
Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine. 2009 Academic Article GET IT
Times cited: 93

more ...

less ...

Background

education and training

Ph.D., University of Montana 79
B.A., Whitman College 73
M.S., University of Montana 1977

Contact

full name

Steven Reed

primary email

sgr2002@med.cornell.edu

VIVO Weill Cornell Medical College

Steven Reed Adjunct Professor of Microbiology in Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email